Clinical Trial

Clinical Evaluation of Skin Microbiome an Over-The-Counter (OTC) Drug for Atopic Dermatitis

Terminated Phase 1
View on ClinicalTrials.gov →
Why the trial stopped
We have decided to close the study due to recruitment challenges.
Summary
This is a research study. The over-the-counter (OTC) drug for atopic dermatitis being tested is not approved as a treatment for the participants' atopic dermatitis condition. In participating in this study, the investigators will analyze the participants' skin microbiome, measure skin hydration and barrier function, and assess clinical improvements to help us understand the potential impact of the investigational OTC drug on atopic dermatitis and skin microbiome balance.
Protocol Amendment History 5 changes
critical Trial terminated 2026-05-28
critical Reason stopped changed: — → We have decided to close the study due to recruitment challenges. 2026-05-28
notable Enrollment reduced: 36 -> 3 participants 2026-05-28
notable Primary completion moved earlier: 2026-09-25 -> 2026-05-12 2026-05-28
minor Completion moved earlier: 2026-11-25 -> 2026-05-12 2026-05-28
Trial Details
NCT Number NCT07146971
Lead Sponsor Good Molecules, LLC
Collaborators: Sequential Skin Inc.
Conditions Atopic Dermatitis (AD)
Enrollment 3 participants
Start Date 2025-08-14
Primary Completion 2026-05-12 (estimated)
Study Completion 2026-05-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-27